What is the size of the South Korea AI Radiology Reimbursement Market?

The South Korea AI Radiology Reimbursement Market was valued at approximately USD 268.4 million. It is projected to grow at a CAGR of around 18.4% during the forecast period of 2026–2030, reaching an estimated USD 624.51 million by 2030.

What are the South Korea AI Radiology Reimbursement Market Drivers?

The major drivers of the South Korea AI Radiology Reimbursement Market include rising imaging workloads across healthcare facilities, increasing demand for workflow automation, and ongoing healthcare digital transformation initiatives. Healthcare providers are increasingly adopting AI-assisted radiology solutions to improve diagnostic efficiency, enhance workflow consistency, and support clinical decision-making. Additionally, the growing focus on outcome-based healthcare delivery, expanding reimbursement pathways for validated imaging algorithms, and the need to address radiologist workload pressures continue to accelerate market growth across South Korea.

What are the segments under the South Korea AI Radiology Reimbursement Market by Reimbursement Payer Type, Imaging Modality Covered, Clinical Radiology Use Case, AI Reimbursement Mechanism, Healthcare Provider Category, and Region?

National Health Insurance Service (NHIS), Private Health Insurance, Employer-Sponsored Health Programs, Government-Funded Special Healthcare Programs, and Others are the segments under the South Korea AI Radiology Reimbursement Market by Reimbursement Payer Type. Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray Imaging, Mammography, Ultrasound Imaging, Nuclear Imaging (PET/SPECT), and Others are the segments by Imaging Modality Covered. Oncology Imaging, Neurology Imaging, Cardiovascular Imaging, Pulmonary & Thoracic Imaging, Musculoskeletal Imaging, Breast Imaging, and Others are the segments by Clinical Radiology Use Case. Separate AI Procedure Reimbursement, Add-on Reimbursement to Imaging Procedure, Bundled Reimbursement within Diagnostic Workflow, Value-Based Reimbursement Models, Pilot & Innovation Funding Programs, and Others are the segments by AI Reimbursement Mechanism. Tertiary General Hospitals, General Hospitals, Specialty Diagnostic & Imaging Centers, Public Healthcare Institutions, Academic & University Hospitals, and Others are the segments by Healthcare Provider Category. Seoul Metropolitan Area, Gyeonggi Province, Busan Metropolitan Area, Daegu-Gyeongbuk Region, and Rest of South Korea are the regional segments under the South Korea AI Radiology Reimbursement Market.

Which is the most dominant region for the South Korea AI Radiology Reimbursement Market?

The Seoul Metropolitan Area is the most dominant region in the South Korea AI Radiology Reimbursement Market, supported by its concentration of tertiary hospitals, academic medical centers, advanced imaging infrastructure, and strong adoption of AI-enabled radiology solutions. Gyeonggi Province is expected to be the fastest-growing region during the forecast period of 2026–2030, driven by expanding healthcare infrastructure, increasing deployment of AI-assisted diagnostic technologies, and growing investment in healthcare modernization. The remaining regions across South Korea continue to experience steady growth due to broader digital healthcare adoption and increasing utilization of AI-supported imaging solutions.

Which Companies are key players in the South Korea AI Radiology Reimbursement Market?

The key players in the South Korea AI Radiology Reimbursement Market include Lunit, VUNO, JLK, Deepnoid, Coreline Soft, AIDOC, Qure.ai, Siemens Healthineers, GE HealthCare, Philips, Fujifilm Healthcare, Canon Medical Systems, Samsung Medison, InferVision, and Riverain Technologies.

South Korea AI Radiology Reimbursement Market | Size, Overview, Trends & Forecast 2026

South Korea AI Radiology Reimbursement Market Research Report – Segmented by Reimbursement Payer Type (National Health Insurance Service (NHIS), Private Health Insurance, Employer-Sponsored Health Programs, Government-Funded Special Healthcare Programs, Others); by Imaging Modality Covered (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray Imaging, Mammography, Ultrasound Imaging, Nuclear Imaging (PET/SPECT), Others); by Clinical Radiology Use Case (Oncology Imaging, Neurology Imaging, Cardiovascular Imaging, Pulmonary & Thoracic Imaging, Musculoskeletal Imaging, Breast Imaging, Others); by AI Reimbursement Mechanism (Separate AI Procedure Reimbursement, Add-on Reimbursement to Imaging Procedure, Bundled Reimbursement within Diagnostic Workflow, Value-Based Reimbursement Models, Pilot & Innovation Funding Programs, Others); by Healthcare Provider Category (Tertiary General Hospitals, General Hospitals, Specialty Diagnostic & Imaging Centers, Public Healthcare Institutions, Academic & University Hospitals, Others); and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)

Published: 2026 - Jun

Report Code: VMR-19444

Region: Asia Pacific

Historic Range: 2023-2025

Forecast: 2026-2032

Format: Excel and PDF

❓ Enquire Before Buying

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

3400

Multi User

3900

Corporate User

4600

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe